↓ Skip to main content

MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol

Overview of attention for article published in BMC Cancer, January 2010
Altmetric Badge

Mentioned by

patent
1 patent

Citations

dimensions_citation
186 Dimensions

Readers on

mendeley
113 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol
Published in
BMC Cancer, January 2010
DOI 10.1186/1471-2407-10-27
Pubmed ID
Authors

Yu Ren, Xuan Zhou, Mei Mei, Xu-Bo Yuan, Lei Han, Guang-Xiu Wang, Zhi-Fan Jia, Peng Xu, Pei-Yu Pu, Chun-Sheng Kang

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 113 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 2%
Switzerland 1 <1%
France 1 <1%
Germany 1 <1%
Romania 1 <1%
Brazil 1 <1%
Spain 1 <1%
China 1 <1%
Unknown 104 92%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 28 25%
Researcher 25 22%
Student > Master 13 12%
Student > Bachelor 11 10%
Other 4 4%
Other 13 12%
Unknown 19 17%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 24 21%
Agricultural and Biological Sciences 24 21%
Medicine and Dentistry 23 20%
Pharmacology, Toxicology and Pharmaceutical Science 6 5%
Chemistry 5 4%
Other 7 6%
Unknown 24 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 October 2021.
All research outputs
#8,759,452
of 25,837,817 outputs
Outputs from BMC Cancer
#2,526
of 9,083 outputs
Outputs of similar age
#52,524
of 175,920 outputs
Outputs of similar age from BMC Cancer
#23
of 42 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 9,083 research outputs from this source. They receive a mean Attention Score of 4.8. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 175,920 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.